Everest Organics Ltd
EVERESTOEverest Organics Ltd
EVERESTOPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-32.21 | 3.71 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Everest Organics Limited is a pharmaceutical company engaged in the business of bulk drugs, intermediates and active pharmaceutical ingredients (APIs).
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 99.85 | 107.87 | 112.87 | 156.39 | 168.66 | 182.63 | 202.26 | 189.98 | 198.13 | 182.51 | ||||||||||
Raw Materials | 61.72 | 71.32 | 72.98 | 97.00 | 103.52 | 117.13 | 141.72 | 126.31 | 124.64 | 176.09 | ||||||||||
Power & Fuel Cost | 7.42 | 9.54 | 10.34 | 10.81 | 11.85 | 12.36 | 14.70 | 18.88 | 15.40 | |||||||||||
Employee Cost | 7.22 | 8.74 | 9.34 | 11.64 | 13.30 | 15.26 | 16.33 | 16.30 | 18.80 | |||||||||||
Selling & Administrative Expenses | 5.02 | 5.45 | 5.54 | 6.33 | 7.34 | 7.65 | 8.66 | 9.75 | 10.52 | |||||||||||
Operating & Other expenses | 12.91 | 5.84 | 6.89 | 12.24 | 11.92 | 6.32 | 12.21 | 10.88 | 16.89 | |||||||||||
EBITDA | 5.56 | 6.98 | 7.78 | 18.37 | 20.73 | 23.91 | 8.64 | 7.86 | 11.88 | 6.42 | ||||||||||
Depreciation/Amortization | 2.73 | 2.45 | 2.68 | 2.84 | 3.21 | 3.37 | 3.80 | 4.47 | 5.80 | 6.12 | ||||||||||
PBIT | 2.83 | 4.53 | 5.10 | 15.53 | 17.52 | 20.54 | 4.84 | 3.39 | 6.08 | 0.30 | ||||||||||
Interest & Other Items | 2.60 | 2.76 | 2.74 | 3.21 | 3.43 | 3.26 | 3.10 | 3.31 | 5.47 | 5.33 | ||||||||||
PBT | 0.23 | 1.77 | 2.36 | 12.32 | 14.09 | 17.28 | 1.74 | 0.08 | 0.61 | -5.03 | ||||||||||
Taxes & Other Items | 0.04 | 0.43 | 0.65 | 4.82 | 3.20 | 3.56 | 0.60 | 0.28 | 0.47 | 0.25 | ||||||||||
Net Income | 0.19 | 1.34 | 1.71 | 7.50 | 10.89 | 13.72 | 1.14 | -0.20 | 0.14 | -5.28 | ||||||||||
EPS | 0.30 | 2.37 | 2.14 | 9.38 | 13.61 | 17.15 | 1.42 | -0.25 | 0.17 | -6.60 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.50 | 0.50 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.11 | 0.07 | 0.09 | 0.35 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Everest Organics Ltd | 1,214.86 | 3.71 | — |
Sun Pharmaceutical Industries Ltd | 45.35 | 6.47 | 0.75% |
Cipla Ltd | 28.51 | 4.38 | 0.89% |
Torrent Pharmaceuticals Ltd | 68.45 | 16.54 | 0.84% |
Price Comparison
Compare EVERESTO with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 15, 2022
Dividend/Share
₹0.50
Ex DateEx Date
Sep 15, 2022
Cash Dividend
Ex DateEx DateSep 8, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Sep 8, 2021
Cash Dividend
Ex DateEx DateFeb 17, 2021
Dividend/Share
₹0.50
Ex DateEx Date
Feb 17, 2021
Cash Dividend
Ex DateEx DateSep 1, 2020
Dividend/Share
₹1.00
Ex DateEx Date
Sep 1, 2020
Cash Dividend
Ex DateEx DateSep 3, 2019
Dividend/Share
₹1.00
Ex DateEx Date
Sep 3, 2019
The headline equity indices traded near flat line with negative bias in early afternoon trade. The Nifty traded below the 24,700 level after hitting day's high of 24,705 in early trade. Metal shares declined after advancing in past two consecutive trading sessions. At 12:26 IST, the barometer index, the S&P BSE Sensex was down 28.10 points or 0.03% to 81,681.02. The Nifty 50 index lost 11.15 points or 0.05% to 24,666.65. The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index rose 0.39% and the S&P BSE Small-Cap index rallied 0.54%. The market breadth was strong. On the BSE, 2,416 shares rose and 1,555 shares fell. A total of 169 shares were unchanged. Derivatives: The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, shed 0.17% to 14.12. The Nifty 26 December 2024 futures were trading at 24,736, at a premium of 69.35 points as compared with the spot at 24,666.65. The Nifty option chain for the 26 December 2024 expiry showed maximum Call OI of 49.6 lakh contracts at the 26,000 strike price. Maximum Put OI of 68.7 lakh contracts was seen at 24,000 strike price. Buzzing Index: The Nifty Metal index slipped 0.75% to 9,326.90. The index rallied 1.80% in past two consecutive trading sessions. Vedanta (down 2.23%), Hindalco Industries (down 2.01%), National Aluminium Company (down 0.72%), NMDC (down 0.67%), JSW Steel (down 0.64%), Hindustan Zinc (down 0.51%), Tata Steel (down 0.5%), Jindal Stainless (down 0.15%), Ratnamani Metals & Tubes (down 0.13%) and Jindal Steel & Power (down 0.12%) declined. On the other hand, Welspun Corp (up 1.67%), APL Apollo Tubes (up 1.23%) and Hindustan Copper (up 0.59%) edged higher. Stocks in Spotlight: Everest Organics hit an upper circuit of 20% after the after the company announced that its board of directors will meet on 10 December 2024 to consider and approve the proposal for fundraising and the appointment of an independent director. Power Finance Corporation rose 0.61%. The company's wholly owned subsidiary, PFC Consulting has incorporated a special purpose vehicle (SPV) company, NER Expansion Transmission the purpose of North-Eastern Region Expansion Scheme-XXV Part-A (NERES-XXV Part-A). One 97 Communications (Paytm) added 0.70%. The company informed that its wholly-owned subsidiary, One97 Communications Singapore (Paytm Singapore), has approved sale of stock acquisition rights (SARs) held in PayPay Corporation, Japan (PayPay) for Rs 2,364 crore.Powered by Capital Market - Live
According to the regulatory filing, the board will discuss and approve a proposal to raise funds through the preferential allotment of equity shares or other securities, subject to necessary approvals, including those from shareholders and regulatory authorities. Additionally, the board will consider the appointment of Narayana Rao as an Independent Director of the company. The official announcement was made on Saturday, 07 December 2024. The company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries. The company commenced its commercial operations in the year 1993. It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project. The company's standalone net profit surged to Rs 74 lakh in Q2 FY25 as against Rs 3 lakh posted in Q2 FY24. However revenue from operations fell 10.9% YoY to Rs 44.05 crore in the quarter ended 30 September 2024. As of 09 December 2024, the company's market capitalization stood at Rs 135.64 crore on the BSE. Powered by Capital Market - Live
Everest Organics will hold a meeting of the Board of Directors of the Company on 10 December 2024Powered by Capital Market - Live
Net profit of Everest Organics rose 2366.67% to Rs 0.74 crore in the quarter ended September 2024 as against Rs 0.03 crore during the previous quarter ended September 2023. Sales declined 10.92% to Rs 44.05 crore in the quarter ended September 2024 as against Rs 49.45 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales44.0549.45 -11 OPM %7.795.48 - PBDT2.221.46 52 PBT0.750.14 436 NP0.740.03 2367 Powered by Capital Market - Live
Everest Organics will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
Everest Organics announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Everest Organics announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Net loss of Everest Organics reported to Rs 6.09 crore in the quarter ended June 2024 as against net profit of Rs 0.04 crore during the previous quarter ended June 2023. Sales declined 23.95% to Rs 32.45 crore in the quarter ended June 2024 as against Rs 42.67 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales32.4542.67 -24 OPM %-11.285.91 - PBDT-4.621.45 PL PBT-6.090.16 PL NP-6.090.04 PL Powered by Capital Market - Live
Everest Organics will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Everest Organics reports standalone net loss of Rs 1.34 crore in the September 2021 quarter
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 4.85%, vs industry avg of 9.03%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.07% to 0.05%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of -54.9%, vs industry avg of 15.27%